share_log

Altria | 10-Q: Q2 2024 Earnings Report

Altria | 10-Q: Q2 2024 Earnings Report

奧馳亞 | 10-Q:2024財年二季報
美股SEC公告 ·  2024/07/31 19:26

牛牛AI助理已提取核心訊息

Altria Group reported Q2 2024 net revenues decreased 4.6% to $6.2 billion, while net earnings surged 79.6% to $3.8 billion, primarily driven by the $2.7 billion gain from the IQOS System commercialization rights sale. Adjusted earnings declined 3.8% to $2.3 billion due to lower operating income. The company recorded a $354 million non-cash impairment charge for the Skoal trademark.Smokeable products segment revenues fell 5.6% to $5.5 billion on lower shipment volumes, while oral tobacco products revenue grew 4.6% to $711 million despite volume declines. Marlboro maintained a 42.0% retail share, while on! nicotine pouches achieved 8.1% share of the oral tobacco category. The company expanded NJOY distribution to over 100,000 stores with 5.5% e-vapor category share.Altria reaffirmed its smoke-free transition vision, targeting 35% smoke-free volume growth and $5 billion in smoke-free revenues by 2028. The company maintained its progressive dividend policy targeting mid-single digit annual growth and completed a $2.4 billion accelerated share repurchase program using proceeds from the partial sale of its ABI stake.
Altria Group reported Q2 2024 net revenues decreased 4.6% to $6.2 billion, while net earnings surged 79.6% to $3.8 billion, primarily driven by the $2.7 billion gain from the IQOS System commercialization rights sale. Adjusted earnings declined 3.8% to $2.3 billion due to lower operating income. The company recorded a $354 million non-cash impairment charge for the Skoal trademark.Smokeable products segment revenues fell 5.6% to $5.5 billion on lower shipment volumes, while oral tobacco products revenue grew 4.6% to $711 million despite volume declines. Marlboro maintained a 42.0% retail share, while on! nicotine pouches achieved 8.1% share of the oral tobacco category. The company expanded NJOY distribution to over 100,000 stores with 5.5% e-vapor category share.Altria reaffirmed its smoke-free transition vision, targeting 35% smoke-free volume growth and $5 billion in smoke-free revenues by 2028. The company maintained its progressive dividend policy targeting mid-single digit annual growth and completed a $2.4 billion accelerated share repurchase program using proceeds from the partial sale of its ABI stake.
奧馳亞集團報告2024年第二季度營業收入減少4.6%,降至62億元,而淨收益激增79.6%,達到38億元,主要得益於27億元的IQOS系統商業化權利出售收益。調整後的收益因營業收入下降而減少3.8%,降至23億元。公司記錄了35400萬元的非現金減值費用,涉及Skoal商標。可吸菸產品部門的收入因出貨量減少而下降5.6%,降至55億元,而口腔煙草製品的收入在成交量下降的情況下增長了4.6%,達到了71100萬元。萬寶路的零售市場份額保持在42.0%,而on! 尼古丁袋在口腔菸草類別中實現了8.1%的市場份額。公司將NJOY的分銷擴大到超過100,000家門店,電子煙類別的市場份額爲5.5%。奧馳亞重申其無煙轉型願景,目標是到2028年實現35%的無煙成交量增長和50億元的無煙營業收入。公司保持其漸進的股息政策,目標是實現中位數的年度增長,並完成了一項價值24億元的加速回購計劃,所用資金來自於其部分出售ABI股份的收益。
奧馳亞集團報告2024年第二季度營業收入減少4.6%,降至62億元,而淨收益激增79.6%,達到38億元,主要得益於27億元的IQOS系統商業化權利出售收益。調整後的收益因營業收入下降而減少3.8%,降至23億元。公司記錄了35400萬元的非現金減值費用,涉及Skoal商標。可吸菸產品部門的收入因出貨量減少而下降5.6%,降至55億元,而口腔煙草製品的收入在成交量下降的情況下增長了4.6%,達到了71100萬元。萬寶路的零售市場份額保持在42.0%,而on! 尼古丁袋在口腔菸草類別中實現了8.1%的市場份額。公司將NJOY的分銷擴大到超過100,000家門店,電子煙類別的市場份額爲5.5%。奧馳亞重申其無煙轉型願景,目標是到2028年實現35%的無煙成交量增長和50億元的無煙營業收入。公司保持其漸進的股息政策,目標是實現中位數的年度增長,並完成了一項價值24億元的加速回購計劃,所用資金來自於其部分出售ABI股份的收益。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。